Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons.
about
HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain.Biologic mechanisms of oral cancer pain and implications for clinical therapyContinuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathyGene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalinGene transfer of glutamic acid decarboxylase reduces neuropathic pain.Adeno-associated viral transfer of opioid receptor gene to primary sensory neurons: a strategy to increase opioid antinociception.Relief of pain induced by varicella-zoster virus in a rat model of post-herpetic neuralgia using a herpes simplex virus vector expressing enkephalin.Gene therapy for pain: results of a phase I clinical trial.Development of viral vectors for gene therapy for chronic painCurrent gene therapy using viral vectors for chronic painHerpes simplex virus-based vectors.Methods for gene transfer to the central nervous system.Immunological thresholds in neurological gene therapy: highly efficient elimination of transduced cells might be related to the specific formation of immunological synapses between T cells and virus-infected brain cells.Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociceptionHSV vector-mediated GAD67 suppresses neuropathic pain induced by perineural HIV gp120 in rats through inhibition of ROS and Wnt5aViral vector-based gene transfer for treatment of chronic pain.From neuroanatomy to gene therapy: searching for new ways to manipulate the supraspinal endogenous pain modulatory system.Herpes vector-mediated gene transfer in the treatment of chronic painApplications of gene therapy to the treatment of chronic pain.Gene therapy directed at the neuroimmune component of chronic pain with particular attention to the role of TNF alpha.A human trial of HSV-mediated gene transfer for the treatment of chronic pain.HSV vector-mediated modification of primary nociceptor afferents: an approach to inhibit chronic pain.A clinical trial of gene therapy for chronic pain.Interleukin 10 mediated by herpes simplex virus vectors suppresses neuropathic pain induced by human immunodeficiency virus gp120 in rats.Targeted drug delivery to the peripheral nervous system using gene therapy.Gene therapy for the treatment of chronic peripheral nervous system pain.Herpes simplex virus-based nerve targeting gene therapy in pain management.Transgene-mediated expression of tumor necrosis factor soluble receptor attenuates morphine tolerance in rats.Modulating pain in the periphery: gene-based therapies to enhance peripheral opioid analgesia: Bonica lecture, ASRA 2010.Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification.Endogenous opioid analgesia in peripheral tissues and the clinical implications for pain control.Treatment of inflamed pancreas with enkephalin encoding HSV-1 recombinant vector reduces inflammatory damage and behavioral sequelae.Gene Therapy for Pain: A PerspectiveTransgene-mediated enkephalin expression attenuates signs of naloxone-precipitated morphine withdrawal in rats with neuropathic pain.Peripheral non-viral MIDGE vector-driven delivery of beta-endorphin in inflammatory pain.Enkephalin-encoding herpes simplex virus-1 decreases inflammation and hotplate sensitivity in a chronic pancreatitis model.Effects of transgene-mediated endomorphin-2 in inflammatory pain.Gene therapy with HSV encoding p55TNFR gene for HIV neuropathic pain: an evidence-based mini-review.
P2860
Q25257395-7A56A010-8F76-4005-A1AE-28948B65987DQ26865216-5A410389-4EDA-4B22-ADC6-87993526C9A4Q28580927-EF9C315E-0EAB-45F7-BA34-92AE207FF5DBQ33792025-238B3E46-E972-4D7C-B8FE-D89A40D45C23Q34062737-65D5658D-534A-48A4-9FBF-BFEE5913A515Q35023218-4D08E6F2-C04E-4F94-9D94-3DE8C87643A0Q35073428-3A521F18-D8AF-4D84-AFE3-F5B799156BAEQ35154100-2F8BAEE9-82A6-49A7-A7D8-AC4AE9A3E3B8Q35430864-4BB026C7-8966-40B1-8D8F-05D0F241A20EQ35658521-4D9A38C5-CEA2-45FD-8FBD-0768FEEB090AQ35863367-B530D4B7-356F-4F64-8CA4-7CF79CF79FADQ35902332-99D40AD4-7841-4EDC-A680-CCBF13F3A8DAQ36274402-4827A63D-9C5C-4FF5-9710-7A0E243350E1Q36634794-F705B9AA-B1BD-4B21-9FE5-CD037DEC1F00Q36777541-2DEF17EF-047C-4352-B8EC-7C3D1BE90E26Q36787828-6A08A742-2315-4A11-BB03-7674ED0A2008Q36861028-A03C73E5-A489-4255-ADD7-5ACE480575DBQ37035292-1BF5266D-856A-41C9-B41F-F5C0A8E6A79BQ37108334-93839D5F-6B38-407E-B482-D8F824831996Q37134881-D675B3DA-F814-4CED-A82E-911CD34EA944Q37195741-980AFE9D-5B83-490E-B8BB-F06365035646Q37439341-88299A30-081C-4436-9C08-0EFB226CF491Q37612033-591CA0AC-D9EF-4A92-BB6C-4B779EC1F1AAQ37656652-E2BAE33D-4437-4B10-A3E1-1828EEE08596Q38008125-42F74531-1A90-4048-899E-4684789AD8CCQ38016275-EC4B5C21-E401-4401-B456-3A16588660A7Q38182564-09B321F2-715B-48F1-AB84-FE4DFC7669F0Q38490798-9F6F0F83-F3F1-4896-BFB2-97DA84EFFDFDQ39673255-0F9F8596-C36D-4663-931E-F674DB9A7AD2Q39756417-1DD73727-0F40-4B2F-97AD-A1B5D1A0A3EBQ39887680-15E656BE-EE3A-43EB-A15F-2957702D1AFFQ41422386-38B40642-EB24-428A-8D9C-FD541896B9EAQ41841809-B99881FB-B517-4B5A-B288-E6A10EEEF02DQ41921009-2A919C2C-109F-452E-AD27-C01534439A86Q42948028-7FA8F6BF-C409-4BF1-9652-6090EABC365AQ43111345-CE116C5A-C305-4D04-B4E0-DDD487754C52Q43161654-C1074F41-0F4F-44CE-83A2-8D95FEED5727Q45874354-4CFB57A2-ABA5-4EE7-8B01-CDC18B7DC22D
P2860
Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Therapeutic efficacy in experi ...... production in sensory neurons.
@en
Therapeutic efficacy in experi ...... production in sensory neurons.
@nl
type
label
Therapeutic efficacy in experi ...... production in sensory neurons.
@en
Therapeutic efficacy in experi ...... production in sensory neurons.
@nl
prefLabel
Therapeutic efficacy in experi ...... production in sensory neurons.
@en
Therapeutic efficacy in experi ...... production in sensory neurons.
@nl
P2093
P1476
Therapeutic efficacy in experi ...... rproduction in sensory neurons
@en
P2093
A L Epstein
C Beaufour
F Cesselin
P304
P356
10.1523/JNEUROSCI.21-20-07881.2001
P407
P577
2001-10-01T00:00:00Z